Skip to content

Clinical trials

Phase 1 Melanoma trials in Canada

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Melanoma Phase: Phase 1 Country / region: Canada Clear all

56 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20011
20081
20101
20111
20123
20132
20153
20166
20175
20181
20196
20206
20214
20229
20234
20242
20251

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed24
Terminated16
Active, not recruiting15
Recruiting1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Pfizer5
National Cancer Institute (NCI)4
Novartis Pharmaceuticals4
Genentech, Inc.3
Hoffmann-La Roche3
University Health Network, Toronto3
Bristol-Myers Squibb2
Karyopharm Therapeutics Inc2
Turnstone Biologics, Corp.2
USWM CT, LLC2

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Melanoma56
Carcinoma, Non-Small-Cell Lung24
Colorectal Neoplasms16
Squamous Cell Carcinoma of Head and Neck15
Carcinoma, Renal Cell13
Neoplasms11
Ovarian Neoplasms9
Triple Negative Breast Neoplasms9
Pancreatic Neoplasms8
Esophageal Neoplasms7

Trials

Showing 1 to 25 of 56. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.